Considering the key role of MDM2 influencing the p53 as well as retinoblastoma pathway, naturally a fine tuning of its biological activity must be of critical importance, as documented by the influence of SNP285/309 haplotype status on cancer risk. This evidence concerns the gene TP53 and cancer.